Signal
Canada joins Germany, Norway and Denmark in restricting or suspending use of the AstraZeneca COVID19 vaccination which has been linked with fatal blood clots among other side effects
NACI recommends that AstraZeneca COVID-19 vaccine should not be used in adults under 55 years of age at this time while the safety signal of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) following vaccination with AstraZeneca COVID-19 vaccine is investigated further.
Rare cases of serious blood clots, including cerebral venous sinus thrombosis, associated with thrombocytopenia have been recently reported in Europe following post-licensure use of AstraZeneca COVID-19 vaccine
Read the Canadian Government’s NACI recommendation
See also
Now Holland stops giving AstraZeneca vaccine to under-60s
Germany suspends use of AstraZeneca’s Covid shot for the under-60s
